Cura Sen Therapeutics Appoints Kathleen Sereda Glaub As CEO and Dr. Anthony Ford As President and CSO

Oct 15, 2024•about 1 year ago

Position

Chief Executive Officer

Company

CuraSen Therapeutics

Kathleen Sereda Glaub

San CarlosBiotechnology

Description

CuraSen Therapeutics, Inc has appointed Kathleen Sereda Glaub as chief executive officer and Dr Anthony Ford as president and chief scientific officer. Along with these changes, the company announced clinical program updates for its drug candidates designed to restore adrenergic stimulus that declines with age or disease.

Company Information

Company

CuraSen Therapeutics

Location

733 Industrial Road

San Carlos, California, United States

About

CuraSen Therapeutics, Inc. is a privately funded biopharmaceutical company pursuing development of novel treatments for neurodegenerative diseases, including Parkinson’s disease and Alzheimer’s disease, as well as several orphan indications. Millions of patients and their families are burdened by these diseases, and the numbers continue to grow annually with the aging population.

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months

Cura Sen Therapeutics Appoints Kathleen Sereda Glaub As CEO and Dr. Anthony Ford As President and CSO

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Executive Insights

Company Information